Johnson & Johnson Vision Introduces the Next Level of Customized Treatment with iDESIGN® Refractive Studio at ESCRS Annual Meeting

iDESIGN® Refractive Studio delivers the first and only LASIK procedure with topography-integrated, wavefront-guided technology 

SANTA ANA, Calif. (October 7, 2017) – Johnson & Johnson Vision today announces the CE mark of its new iDESIGN® Refractive Studio, which integrates corneal topography measurements into the current wavefront-guided treatment to deliver the next level of customized treatment for patients undergoing laser vision correction surgery. 

The five-in-one iDESIGN® System captures more than 1,200 micro readings of the eye to give a precise refraction. The shape and curvature of the cornea are also precisely measured in a single three-second scan. This information is used for both patient screening and treatment planning. The uniquely customized iDESIGN Procedure drives high patient satisfaction and delivers quality visual outcomes. 

“Johnson & Johnson Vision’s new iDESIGN® Refractive Studio integrates the latest topography mapping into our wavefront-guided technology, enabling surgeons to measure the entire visual pathway and create an optical fingerprint unique to each patient’s eye,” said Tom Frinzi, Worldwide President, Surgical, Johnson & Johnson Vision. “This advanced software ushers in the next level of customization.” 

iDESIGN® Refractive Studio offers important advancements to improve customized treatment planning, patient qualification, diagnostics, and practice workflow. 

Johnson & Johnson Vision will release iDESIGN® Refractive Studio through its surgical vision operating company, Abbott Medical Optics Inc. 


Johnson & Johnson Vision 

Johnson & Johnson Vision, through its operating companies, is committed to improving and restoring sight for patients worldwide. Since debuting the world’s first disposable soft contact lens in 1987, Johnson & Johnson Vision Care, Inc. has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, with the addition of Abbott Medical Optics Inc., the Johnson & Johnson Surgical Vision business, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK) and consumer eye health. Serving more than 60 million patients across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight. Dual headquartered in Jacksonville, Florida, and Santa Ana, California, Johnson & Johnson Vision has more than 10,000 employees worldwide. 

Media Contact: 
Kim Montagnino 
(631) 375-8779 

# # # 

© 2017 AMO Manufacturing USA, LLC. iDESIGN is a trademark owned by or licensed to AMO Manufacturing USA, LLC, its subsidiaries or affiliates. All other trademarks are the intellectual property of their respective owners.PP2017RF0286